123 related articles for article (PubMed ID: 10211918)
1. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.
Bauer M; Zaninelli R; Müller-Oerlinghausen B; Meister W
J Clin Psychopharmacol; 1999 Apr; 19(2):164-71. PubMed ID: 10211918
[TBL] [Abstract][Full Text] [Related]
2. Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
Zaninelli R; Bauer M; Jobert M; Müller-Oerlinghausen B
J Clin Psychopharmacol; 2001 Apr; 21(2):190-8. PubMed ID: 11270916
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.
Hutchinson DR; Tong S; Moon CA; Vince M; Clarke A
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():43-51. PubMed ID: 1431010
[TBL] [Abstract][Full Text] [Related]
4. A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group.
Bignamini A; Rapisarda V
Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():37-41. PubMed ID: 1431009
[TBL] [Abstract][Full Text] [Related]
5. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I
Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
[TBL] [Abstract][Full Text] [Related]
6. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
7. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice.
Freed E; Goldney R; Lambert T; Tiller J; Johnston R
Aust N Z J Psychiatry; 1999 Jun; 33(3):416-21. PubMed ID: 10442799
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine compared with paroxetine in major depression.
Benkert O; Szegedi A; Kohnen R
J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
[TBL] [Abstract][Full Text] [Related]
11. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
Laursen AL; Mikkelsen PL; Rasmussen S; le Fèvre Honoré P
Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine versus placebo: a double-blind comparison in depressed patients.
Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study).
Battegay R; Hager M; Rauchfleisch U
Neuropsychobiology; 1985; 13(1-2):31-7. PubMed ID: 3162108
[TBL] [Abstract][Full Text] [Related]
14. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Pezzella G; Moslinger-Gehmayr R; Contu A
Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of major depressive disorder with paroxetine.
Duboff EA
J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):28S-33S. PubMed ID: 8106653
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine and amitriptyline in the treatment of depression in general practice.
Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J
Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Bird H; Broggini M
J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
[TBL] [Abstract][Full Text] [Related]
18. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Baldwin D; Bridgman K; Buis C
J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
[TBL] [Abstract][Full Text] [Related]
20. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
